Showing 3 posts of 3 posts found.

Eliquis fails in head-to-head study against Lovenox

November 14, 2011
Research and Development, Sales and Marketing BMS, Eliquis, Lovenox, Pfizer

Bristol-Myers Squibb and Pfizer have suffered a setback in their attempts to cement Eliquis’ place in the $20 billion market …

Generic Lovenox to dent Sanofi’s earnings

July 26, 2010
Sales and Marketing Lovenox, Sandoz, Sanofi-Aventis, generics

A generic version of Sanofi-Aventis’ blockbuster anti-blood clot treatment Lovenox has just gained approval in the US, signaling a rapid …

Blood clot

Encouraging data for ThromboGenics and BioInvent product

May 7, 2010
BioInvent, Lovenox, ThromboGenics, VTE

An antibody-based drug to prevent blood clots after orthopaedic surgery has shown promising results in phase II. TB-402 is a …

Latest content